Companies: 10,795·Total market cap: $144.5T

Silence Therapeutics plc

Silence Therapeutics plc

SLNNASDAQHealthcare● Active

$6.23

+$0.06(+0.97%)

Market Cap$294267496

P/E Ratio—

52W High$8.4

52W Low$4.19

Avg Volume331K

Open$6.24

Beta1.44

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Silence Therapeutics plc（SLN）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · SLN · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-4.32Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)921490.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding47.2MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Silence Therapeutics plc 数据

分析师预测$57 · Buy

股息不分红

营收$559000-98.71%

盈利EPS $-1.89+20.25%

财务快照

FY 2025Revenue$559000.00▼ 98.71% YoY

202320242025

FY 2025Net Income-$88.6M▼ 95.57% YoY

202320242025

FY 2025EPS$-1.89▲ +20.25% YoY

202320242025

TTM:Revenue: $921490.00Net Income: -$85.2MEPS: $-4.32View income statement →

分析师评级与目标价

Buy5 位分析师

Strong Buy

0

Buy

4

Hold

0

Sell

1

Strong Sell

0

12-Month Price Target

$49.00Low

$6.23Current

$57.00Avg Target上涨空间 814.93%

$67.00High

合计: 5 · 买入占比: 80.0%

根据过去 3 个月内 5 位华尔街分析师，SLN 共识评级为 Buy，12 个月平均目标价 $57.00 （较现价 $6.23 上涨空间 814.93%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Silence Therapeutics plc

$6.23+0.97%$294.3M #2

$2.20-2.67%$223.4M #3

Aldeyra Therapeutics, Inc.

$1.74+6.75%$105.0M #4

Amarin Corporation plc

$14.20+1.94%$293.7M #5

Alto Neuroscience, Inc.

$18.25-0.11%$640.5M #6

Capricor Therapeutics, Inc.

$26.13-2.06%$1.2B

股票表现

1D-0.65%

1W-3.62%

1M-12.05%

3M-1.61%

YTD+0.82%

1Y+15.44%

5Y-77.09%

关于 Silence Therapeutics plc

CEOIain Gladstone Ross

IPO DateSep 8, 2020

Employees116

CountryGB

Websitesilence-therapeutics.com

Silence Therapeutics plc is a London, UK-based biotechnology company specializing in the research and development of groundbreaking ribonucleic acid (RNA) therapeutics. Its therapeutic focus areas inc…

Biotechnology HealthcareNASDAQADRGB

关于股票概览与关键数据

Silence Therapeutics plc（SLN）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 8, 2020 在 NASDAQ 上市。截至最近交易日，SLN 股价为 $6.23，市值约为 $294.3M。过去12个月累计回报 +15.44%，年初至今回报 +0.82%。

根据 5 位华尔街分析师，Silence Therapeutics plc 股票共识评级为Buy，12个月平均目标价为 $57.00。2025 财年 Silence Therapeutics plc 营收 $559000.00，净利润 -$88.6M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Silence Therapeutics plc（SLN）股价为 $6.23，在 NASDAQ 上市，52周区间为 $4.19 – $8.40。

SLN 最新股价SLN quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议